PACK 5 INSULATED #191640076-5PK 10-12GA YELLOW DISCONN QUICK FEMALE SHRINK HEAT Car Audio & Video Connectors & Terminals


  1. Home
  2. PACK 5 INSULATED #191640076-5PK 10-12GA YELLOW DISCONN QUICK FEMALE SHRINK HEAT
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
5 PACK  INSULATED HEAT SHRINK FEMALE QUICK DISCONN YELLOW 10-12GA #191640076-5PK
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Color:

Yellow

Type: Ring Terminal Brand:

CES

MPN:

191640076-5PK

Gauge: 10-12 AWG
Country/Region of Manufacture: China Model:

191640076-5PK

UPC:

Does not apply



published on tue nov 09 2021

PACK 5 INSULATED #191640076-5PK 10-12GA YELLOW DISCONN QUICK FEMALE SHRINK HEAT Car Audio & Video Connectors & Terminals

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

PACK 5 INSULATED #191640076-5PK 10-12GA YELLOW DISCONN QUICK FEMALE SHRINK HEAT Car Audio & Video Connectors & Terminals

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS